Zobrazeno 1 - 10
of 469
pro vyhledávání: '"Kenta, Murotani"'
Autor:
Yuria Ishida, Keisuke Maeda, Kenta Murotani, Akio Shimizu, Junko Ueshima, Ayano Nagano, Tatsuro Inoue, Naoharu Mori
Publikováno v:
Annals of Geriatric Medicine and Research, Vol 28, Iss 2, Pp 171-177 (2024)
Background The association of the combination of body mass index (BMI) and weight change at admission with prognoses in patients with heart failure (HF) is unclear. Therefore, we investigated whether BMI and weight changes at admission affect mortali
Externí odkaz:
https://doaj.org/article/ea130bab7c5847b5940aa93618880685
Autor:
Yukitoshi Ikeya, Yasuo Okumura, Rikitake Kogawa, Koichi Nagashima, Toshiko Nakai, Katsuaki Yokoyama, Kazuki Iso, Takeshi Kato, Toyonobu Tsuda, Eizo Tachibana, Satoshi Hayashida, Hidehira Fukaya, Naruya Ishizue, Hidemori Hayashi, Shunsuke Kuroda, Kazumasa Sonoda, Shiro Nakahara, Yuichi Hori, Masahide Harada, Masato Murakami, Yu‐Ki Iwasaki, Yoshiyasu Aizawa, Wataru Shimizu, Seiji Fukamizu, Mitsuru Takami, Kengo Kusano, Kohei Ishibashi, Tomoo Harada, Ikutaro Nakajima, Haruna Tabuchi, Mitsuhiro Kunimoto, Morio Shoda, Satoshi Higuchi, Itsuro Morishima, Yasunori Kanzaki, Ritsushi Kato, Yoshifumi Ikeda, Hisaki Makimoto, Tomoyuki Kabutoya, Kazuomi Kario, Takanori Arimoto, Yuichi Ninomiya, Issei Yoshimoto, Shingo Sasaki, Yusuke Kondo, Toshinori Chiba, Kennosuke Yamashita, Yosuke Mizuno, Masaru Inoue, Takeshi Ueyama, Jyunjiro Koyama, Takuo Tsurugi, Yoshiya Orita, Taku Asano, Toshiro Shinke, Kaoru Tanno, Kenta Murotani, For the TRANSITION JAPAN‐ICD/WCD study
Publikováno v:
Journal of Arrhythmia, Vol 40, Iss 3, Pp 423-433 (2024)
Abstract Background Despite the positive impact of implantable cardioverter defibrillators (ICDs) and wearable cardioverter defibrillators (WCDs) on prognosis, their implantation is often withheld especially in Japanese heart failure patients with re
Externí odkaz:
https://doaj.org/article/bb69a8079046485b91b2930ed2e2febe
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Previous studies have demonstrated associations between enlarged perivascular spaces (EPVS) and dementias such as Alzheimer’s disease. However, an association between EPVS and dementia with Lewy bodies (DLB) has not yet been clarified. We
Externí odkaz:
https://doaj.org/article/33ac800e5b2941cca8d2d0aa35851475
Autor:
Takao Kato, Nozomu Kotorii, Motohiro Ozone, Kenta Murotani, Hayato Ohshima, Hiroyuki Mori, Kenjirou Wasano, Hiroshi Hiejima, Mitsunari Habukawa, Naohisa Uchimura
Publikováno v:
Neuropsychopharmacology Reports, Vol 44, Iss 1, Pp 80-89 (2024)
Abstract Aims In Japan, the daily dosage of hypnotic drugs for insomnia treatment is increasing year by year, and over‐dependence on treatment with hypnotic drugs is a major problem. This study aimed to examine the factors related to the eliminatio
Externí odkaz:
https://doaj.org/article/e2035cb1a7274e358101b57075df11a2
Autor:
Nana Kimura, Takamichi Igarashi, Kenta Murotani, Ayaka Itoh, Toru Watanabe, Katsuhisa Hirano, Haruyoshi Tanaka, Kazuto Shibuya, Isaku Yoshioka, Tsutomu Fujii
Publikováno v:
Annals of Gastroenterological Surgery, Vol 8, Iss 2, Pp 301-311 (2024)
Abstract Background There have been few studies of countermeasures against postoperative cholangitis, a serious complication after pancreaticoduodenectomy (PD) that impairs quality of life. Objective To evaluate our recently developed, novel method o
Externí odkaz:
https://doaj.org/article/bc05b2d4afb14f07add589c0337450c7
Autor:
Yutaka Fujiwara, Kazuhiro Shimomura, Teppei Yamaguchi, Junichi Shimizu, Naohiro Watanabe, Reiko Matsuzawa, Kenta Murotani, Yoshitsugu Horio
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Interstitial lung disease (ILD) or pneumonitis caused by epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) or immune checkpoint inhibitors (ICI) is a major concern in the treatment of non-small cell lung cancer (NSCLC). Whether
Externí odkaz:
https://doaj.org/article/34ee6869c9004bd38ecb781f3c16fe80
Autor:
Daiki Murata, Koichi Azuma, Norikazu Matsuo, Kenta Murotani, Goushi Matama, Akihiko Kawahara, Tetsuro Sasada, Takaaki Tokito, Tomoaki Hoshino
Publikováno v:
Cancer Medicine, Vol 12, Iss 19, Pp 19471-19479 (2023)
Abstract Background The presence of cachexia negatively impacts the prognosis of patients with cancer. However, the mechanisms behind the development of cachexia and its prognostic impact on immunotherapy efficacy are not fully understood. Materials
Externí odkaz:
https://doaj.org/article/a57828e9043e4693aff7c36881ad6d56
Autor:
Shun Horaguchi, Yoshiro Nakahara, Yuka Igarashi, Taku Kouro, Feifei Wei, Kenta Murotani, Seiichi Udagawa, Naoko Higashijima, Norikazu Matsuo, Shuji Murakami, Terufumi Kato, Tetsuro Kondo, Huihui Xiang, Rika Kasajima, Hidetomo Himuro, Kayoko Tsuji, Yasunobu Mano, Mitsuru Komahashi, Yohei Miyagi, Haruhiro Saito, Koichi Azuma, Shuichiro Uehara, Tetsuro Sasada
Publikováno v:
Biomedicines, Vol 12, Iss 8, p 1831 (2024)
Neutrophil extracellular traps (NETs) released from neutrophils are related to cancer progression. However, the relationship between the therapeutic effects of immune checkpoint inhibitors (ICIs) such as anti-PD-1 and anti-PD-L1 antibodies and plasma
Externí odkaz:
https://doaj.org/article/4b39897048e4485b88664befbd1be51d
Autor:
Ryota Otsubo, Ryuki Hashida, Kenta Murotani, Sohei Iwanaga, Keisuke Hirota, Shunji Koya, Yuya Tsukada, Yuta Ogata, Kimiaki Yokosuka, Tatsuhiro Yoshida, Ichiro Nakae, Takuma Fudo, Shinji Morito, Takahiro Shimazaki, Kei Yamada, Kimiaki Sato, Hiroo Matsuse, Naoto Shiba, Koji Hiraoka
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract Lumbar spinal stenosis (LSS) can interfere with daily life and quality of life (QOL). Evaluating physical function and QOL and helping patients to improve is the focus of rehabilitation. Phase angle (PhA) assessment is widely used to measure
Externí odkaz:
https://doaj.org/article/b98641b4e6b54a13a2311de593d784e9
Autor:
Shingo Tsuneyoshi, Yoshiaki Zaizen, Masaki Tominaga, Goushi Matama, Shushi Umemoto, Shuuhei Ohno, Reiko Takaki, Ryo Yano, Kenta Murotani, Masaki Okamoto, Tomoaki Hoshino
Publikováno v:
BMC Pulmonary Medicine, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Nintedanib is now widely used to treat interstitial lung disease (ILD). Adverse events, which occur in not a few patients, make it difficult to continue nintedanib treatment, but the risk factors for adverse events are not well un
Externí odkaz:
https://doaj.org/article/a0b9845f1de34fcb8ef5c4bffc6cac46